Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €86.00 EUR
Change Today 0.00 / 0.00%
Volume 0.0
LLY On Other Exchanges
SIX Swiss Ex
Sao Paulo
EN Paris
As of 4:02 AM 11/26/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ELI LILLY & CO (LLY) in the last 6 months

Announced 11/6/15
30.00M for Ignyta, Inc.
Private Placement

Ignyta, Inc. (NasdaqCM:RXDX) announced a private placement of 1,500,000 unregistered common shares at $20 per share with existing investor, Eli Lilly and Company for gross proceeds of $30,000,000 on November 6, 2015. The company has signed an agreement with the investor. The company will issue securities pursuant to exemption provided under Regulation D. The investor, without the company’s prior written consent, offer, pledge, sell, contract to sell, sell any option ...
Read More

LLY's price was unchanged after the transaction was announced on 11/6/15.
Investor / Buyer
Eli Lilly and Company
Announced 10/9/15
Locemia Solutions, LP

Eli Lilly and Company (NYSE:LLY) acquired Locemia Solutions, LP from Windham Venture Partners, Robert Oringer, Walt Winshall and others October 9, 2015. Raymond Gietz of Weil Gotshal & Manges acted as legal advisor for Eli Lilly.

LLY's price was unchanged after the transaction was announced on 10/9/15.
Investor / Buyer
Eli Lilly and Company
Creditor / Lender
Windham Venture Partners
Announced 07/16/15
205.00M for Immunocore Limited
Private Placement

Immunocore Limited announced that it has received £205 million in its series A round of funding led by new investor, Malin Corporation plc on July 16, 2015. The oversubscribed transaction included participation from other new investors, Woodford Investment Management LLP, Eli Lilly and Company and RTW Investments, LLC and other new and existing investors. Malin Corporation plc invested £51,170,200 ($80,000,000) in the transaction. As part of the transaction, Adrian Howd, ...
Read More

LLY's price was unchanged after the transaction was announced on 07/16/15.
Investor / Buyer
Eli Lilly and Company
Malin Corporation plc
RTW Investments, LLC
Woodford Investment Management LLP
Legal Advisor
Cooley LLP

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:FP €86.00 EUR 0.00

LLY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $45.42 USD +0.01
AbbVie Inc $60.00 USD -0.29
AstraZeneca PLC 4,513 GBp -7.50
Medtronic PLC $76.46 USD -0.10
Novo Nordisk A/S kr386.00 DKK +0.30
View Industry Companies

Industry Analysis


Industry Average

Valuation LLY Industry Range
Price/Earnings 37.9x
Price/Sales 4.5x
Price/Book 5.8x
Price/Cash Flow 39.3x
TEV/Sales 4.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at